Any current/future new fundraising through debt or equity?

No explicit mention of new fundraising through debt or equity during the call. Management emphasizes deleveraging with expected reduction in net debt-to-EBITDA ratio from 2.1x to between 1.6x-1.8x by March 2026, indicating net debt is expected to decrease rather than increase. Upcoming debt maturities (e.g., $500 million in March 2026 and $400 million in September 2026) are planned to be met through operational cash flow, existing cash balances, and unutilized working capital lines. IPO of Advanta is planned as an offer-for-sale, with cash proceeds going to existing shareholders (UPL and KK

Any current/future capex/capital investment/strategic investment?

The document does not explicitly mention specific current or future capex or capital investment amounts. There is a focus on strategic investments in new product launches, particularly in the crop protection segment, with a strong new product pipeline exceeding $130 million revenue target for new products this year. Emphasis on operational excellence and manufacturing excellence contributing to cost reductions. Advancement in sustainable solutions category with 11% revenue growth reflects strategic investment in this segment. Advanta (seeds business) is undergoing corporate actions including I

Future growth expectations in sales/revenue/volumes?

UPL expects full-year FY '26 revenue growth of 4% to 8% and EBITDA growth of 12% to 16%. (Page 10) The company anticipates volume-led growth in Q4, supported by in-season demand and higher revenues from new product launches. (Page 8) New product launches are on track to exceed a $130 million revenue target in FY '26, with strong traction in Brazil and LATAM, expected to accelerate in Q4. (Page 9) Regional growth expected in Q4 across all markets, including Europe, North America, Latin America, Africa, and Asia Pacific. (Pages 9-11) North America’s growth expected to be stronger in Q4 due to de

Future growth expectations in earnings/operating earnings/profits/EPS?

UPL maintains full-year FY '26 guidance with expectations of 4% to 8% revenue growth and 12% to 16% EBITDA growth. Q4 anticipated to see growth across all regions, supported by strong in-season demand and new product launches. Contribution margins expected to expand due to improved product mix, higher capacity utilization, and lower input costs. Management confident in delivering strong Q4 results focusing on top line, bottom line, and cash generation. EBITDA growth is strong year-to-date, with 22% growth over 9 months and margin improvements. Profit before tax (PBT) increased significantly by

IN US

Sale is live|00:00:00left today

UPL LtdQ4 FY27Fertilizers & Agrochemicals

UPL Ltd Q4 FY27 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹600P/E: 28.2Market Cap: ₹53.4K CrSector: Fertilizers & Agrochemicals

Management growth scorecard

Revenue

Category 4

Margin

Category 3

Fundraise

Order

N/A

Capex

N/A

0 of 3 growth signals are positive — mixed outlook.

Full analysis

Revenue guidance

Category 4

→UPL expects full-year FY '26 revenue growth of 4% to 8% and EBITDA growth of 12% to 16%. (Page 10)
→The company anticipates volume-led growth in Q4, supported by in-season demand and higher revenues from new product launches. (Page 8)
→New product launches are on track to exceed a $130 million revenue target in FY '26, with strong traction in Brazil and LATAM, expected to accelerate in Q4. (Page 9)
→Regional growth expected in Q4 across all markets, including Europe, North America, Latin America, Africa, and Asia Pacific. (Pages 9-11)
→North America’s growth expected to be stronger in Q4 due to delayed sales from Q3 and strong herbicide demand. (Page 11)
→Sustainable solutions are scaling, delivering strong growth, particularly in Europe and Asia Pacific with 11% revenue growth in Q3. (Page 7)
→Market cautiousness remains due to tariff uncertainty and trade issues, but overall momentum is positive. (Pages 7, 11)

Margin guidance

Category 3

→UPL maintains full-year FY '26 guidance with expectations of 4% to 8% revenue growth and 12% to 16% EBITDA growth.
→Q4 anticipated to see growth across all regions, supported by strong in-season demand and new product launches.
→Contribution margins expected to expand due to improved product mix, higher capacity utilization, and lower input costs.
→Management confident in delivering strong Q4 results focusing on top line, bottom line, and cash generation.
→EBITDA growth is strong year-to-date, with 22% growth over 9 months and margin improvements.
→Profit before tax (PBT) increased significantly by 90% Y-o-Y in Q3, supported by reduced finance costs and improved joint venture performance.
→The company aims for sustainable improvement in business quality and operational efficiency.
→Earnings growth driven by volume expansion, new products, cost control, and debt reduction initiatives.

3 more insights locked — sign up free to unlock

Fundraise plans

→No explicit mention of new fundraising through debt or equity during the call.
→Management emphasizes deleveraging with expected reduction in net debt-to-EBITDA ratio from 2.1x to between 1.6x-1.8x by March 2026, indicating net debt is expected to decrease rather than increase.
→Upcoming debt maturities (e.g., $500 million in March 2026 and $400 million in September 2026) are planned to be met through operational cash flow, existing cash balances, and unutilized working capital lines.
→IPO of Advanta is planned as an offer-for-sale, with cash proceeds going to existing shareholders (UPL and KKR) for deleveraging, not as a primary capital raise for Advanta.
→Management is comfortable with cash position and options to handle capital structure as required but no mention of new debt or equity fundraising at this time.

Order book

The provided transcript from UPL Limited's Q3 & 9MFY26 earnings call does not explicitly mention current or expected order book or pending orders figures. However, some relevant information that implies strong demand and order momentum includes: - Strong momentum and confidence in Q4 performance, with growth expected across all regions. - January reinforced confidence due to solid order intake and customer engagement. - Record high prepay dollars in the U.S., indicating strong distributor commitments and order pipeline. - Strong in-season demand and higher revenues anticipated in Q4 from new product launches. - Supply chain readiness for a strong Q4, implying anticipated order fulfillment. - Overall cautious but positive outlook for revenue and EBITDA growth for the full financial year. No specific quantification of order book or pending orders is provided in the transcript.

Capex plans

→The document does not explicitly mention specific current or future capex or capital investment amounts.
→There is a focus on strategic investments in new product launches, particularly in the crop protection segment, with a strong new product pipeline exceeding $130 million revenue target for new products this year.
→Emphasis on operational excellence and manufacturing excellence contributing to cost reductions.
→Advancement in sustainable solutions category with 11% revenue growth reflects strategic investment in this segment.
→Advanta (seeds business) is undergoing corporate actions including IPO filing, indicating strategic investment in value unlocking and possible future capital allocation.
→Management is investing selectively in SG&A towards growth and enterprise-wide transformation initiatives.
→Debt repayment and deleveraging efforts indicate disciplined capital management but no direct mention of large capex outlays.
→Overall, strategic focus appears to be on product innovation, market expansion, and ESG leadership rather than heavy capital expenditure.

How does UPL Ltd rank vs peers in Fertilizers & Agrochemicals?

Pro feature

1UPL Ltd

Rev 4Mar 3

See full Fertilizers & Agrochemicals sector rankings

Want more stocks like UPL Ltd?

Build an AI portfolio filtered by sector, market cap, and growth rank. Takes 2 minutes.

Build my portfolio